Active Pharmaceutical Ingredient (Generic)

REGORAFENIB

🩺 ANTINEOPLASTICS 💊 2 Marketed Brands
Clinical Profile:

*Metastatic colorectal cancer, Unresectable or metastatic gastrointestinal stromal tumours, Hepatocellular carcinoma (specialist use only):* Adult: 160 mg once daily for 21 consecutive days of repeated 28-day cycles, for dose adjustment consult product literature.

Marketed Brands Containing REGORAFENIB (2) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
REGONIX 🏢 HIMMEL
Tab 40 mg 28: Rs.66000.00
View Details →
STIVARGA 🏢 BAYER
Tab 40 mg 28x3: Rs.360000.00
View Details →